Miguel Ganuza

Miguel Ganuza

Auto-generated profile, based on publicly available information

Miguel Ganuza

Centre for Haemato‐Oncology, Barts Cancer Institute Queen Mary University of London London UK

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2012 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
MGMiguel Ganuza
Miguel Ganuza
CSCristina Sáiz‐Ladera
Cristina Sáiz‐Ladera
MCMarta Cañamero
Marta Cañamero
Gonzalo Gomez-LopezGonzalo Gomez-Lopez
Gonzalo Gomez-Lopez
RSRalph Schneider
Ralph Schneider
MBMariano Barbacid
Mariano Barbacid
Cyclin‐dependent kinase (Cdk)7, the catalytic subunit of the Cdk‐activating kinase (CAK) complex has been implicated in the control of cell cycle progression and of RNA polymerase II (RNA pol II)‐mediated transcription. Genetic inactivation of the Cdk7 locus revealed that whereas Cdk7 is completely dispensable for global transcription, is essential for the cell cycle via phosphorylation of Cdk1 and Cdk2. In vivo , Cdk7 is also indispensable for cell proliferation except during the initial stages of embryonic development. Interestingly, widespread elimination of Cdk7 in adult tissues with low proliferative indexes had no phenotypic consequences. However, ablation of conditional Cdk7 alleles in tissues with elevated cellular turnover led to the efficient repopulation of these tissues with Cdk7‐expressing cells most likely derived from adult stem cells that may have escaped the inactivation of their targeted Cdk7 alleles. This process, a physiological attempt to maintain tissue homeostasis, led to the attrition of adult stem cell pools and to the appearance of age‐related phenotypes, including telomere shortening and early death.

15 February 2016 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
PHPer Holmfeldt
Per Holmfeldt
MGMiguel Ganuza
Miguel Ganuza
HMHimangi Marathe
Himangi Marathe
BHBing He
Bing He
THTrent Hall
Trent Hall
SMShannon McKinney-Freeman
Shannon McKinney-Freeman
Understanding the molecular regulation of hematopoietic stem and progenitor cell (HSPC) engraftment is paramount to improving transplant outcomes. To discover novel regulators of HSPC repopulation, we transplanted >1,300 mice with shRNA-transduced HSPCs within 24 h of isolation and transduction to focus on detecting genes regulating repopulation. We identified 17 regulators of HSPC repopulation: Arhgef5, Armcx1, Cadps2, Crispld1, Emcn, Foxa3, Fstl1, Glis2, Gprasp2, Gpr56, Myct1, Nbea, P2ry14, Smarca2, Sox4, Stat4, and Zfp251. Knockdown of each of these genes yielded a loss of function, except in the cases of Armcx1 and Gprasp2, whose loss enhanced hematopoietic stem cell (HSC) repopulation. The discovery of multiple genes regulating vesicular trafficking, cell surface receptor turnover, and secretion of extracellular matrix components suggests active cross talk between HSCs and the niche and that HSCs may actively condition the niche to promote engraftment. We validated that Foxa3 is required for HSC repopulating activity, as Foxa3−/− HSC fails to repopulate ablated hosts efficiently, implicating for the first time Foxa genes as regulators of HSPCs. We further show that Foxa3 likely regulates the HSC response to hematologic stress. Each gene discovered here offers a window into the novel processes that regulate stable HSPC engraftment into an ablated host.

18 September 2017 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
MGMiguel Ganuza
Miguel Ganuza
THTrent Hall
Trent Hall
DFDavid Finkelstein
David Finkelstein
ACAshley Chabot
Ashley Chabot
GKGuolian Kang
Guolian Kang
SMShannon McKinney-Freeman
Shannon McKinney-Freeman

6 October 2022 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
MGMiguel Ganuza
Miguel Ganuza
THTrent Hall
Trent Hall
JMJacquelyn Myers
Jacquelyn Myers
CNChris Nevitt
Chris Nevitt
RSRaúl Sánchez-Lanzas
Raúl Sánchez-Lanzas
SMShannon McKinney-Freeman
Shannon McKinney-Freeman

2 May 2019 in Blood
Verified
Journal Article
Closed access
PDF file
MGMiguel Ganuza
Miguel Ganuza
THTrent Hall
Trent Hall
DFDavid Finkelstein
David Finkelstein
YWYong-Dong Wang
Yong-Dong Wang
ACAshley Chabot
Ashley Chabot
SMShannon McKinney-Freeman
Shannon McKinney-Freeman
Although many recent studies describe the emergence and prevalence of 9clonal-hematopoiesis of indeterminate-potential9 (CHIP) in aged human populations, a systematic analysis of the numbers of clones supporting steady-state hematopoiesis throughout mammalian life is lacking. Previous efforts relied on transplantation of 9barcoded9 hematopoietic stem cells (HSC) to track the contribution of HSC clones to reconstituted blood. However, ex vivo manipulation and transplantation alter HSC function and thus may not reflect the biology of steady-state hematopoiesis. Using a non-invasive in vivo color-labeling system, we report the first comprehensive analysis of the changing global clonal complexity of steady-state hematopoiesis during the natural murine lifespan. We observed that the number of clones (i.e. clonal complexity) supporting the major blood and bone marrow hematopoietic compartments decline with age by about 30% and 60%, respectively. Aging dramatically reduced HSC in vivo repopulating activity and lymphoid potential while increasing functional heterogeneity. Continuous challenge of the hematopoietic system by serial transplantation provoked the clonal collapse of both young and aged hematopoietic systems. Whole exome sequencing of serially transplanted aged and young hematopoietic clones confirmed oligoclonal hematopoiesis and revealed mutations in at least 27 genes, including nonsense, missense and deletion mutations in Bcl11b, Hist1h2ac, Npy2r, Notch3, Ptprr and Top2b. Key points The clonal diversity of the hematopoietic system declines with age and after serial transplantation. Aged HSC acquire mutations that might confer a selective advantage during serial transplantation.

20 December 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
MGMiguel Ganuza
Miguel Ganuza
ACAshley Chabot
Ashley Chabot
XTXing Tang
Xing Tang
WBWenjian Bi
Wenjian Bi
SNSivaraman Natarajan
Sivaraman Natarajan
SMShannon McKinney-Freeman
Shannon McKinney-Freeman
The embryonic site of definitive hematopoietic stem cell (dHSC) origination has been debated for decades. Although an intra-embryonic origin is well supported, the yolk sac (YS) contribution to adult hematopoiesis remains controversial. The same developmental origin makes it difficult to identify specific markers that discern between an intraembryonic versus YS-origin using a lineage trace approach. Additionally, the highly migratory nature of blood cells and the inability of pre-circulatory embryonic cells (i.e., 5–7 somite pairs (sp)) to robustly engraft in transplantation, even after culture, has precluded scientists from properly answering these questions. Here we report robust, multi-lineage and serially transplantable dHSC activity from cultured 2–7sp murine embryonic explants (Em-Ex). dHSC are undetectable in 2–7sp YS explants. Additionally, the engraftment from Em-Ex is confined to an emerging CD31+CD45+c-Kit+CD41−population. In sum, our work supports a model in which the embryo, not the YS, is the major source of lifelong definitive hematopoiesis.